Kornélia Baghy

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2014-2023
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Transforming Growth Factor

Top Venues

American journal of physiology. Cell physiology

BioMed research international

This page only lists publications with an associated author ORCID identifier.

Publications

Gábor Petővári, Gábor Tóth, Lilla Turiák, Anna L Kiss, Krisztina Pálóczi, Anna Sebestyén, Adrián Pesti, András Kiss, Kornélia Baghy, Katalin Dezső, Tibor Füle, Péter Tátrai, Ilona Kovalszky, Andrea Reszegi
Dynamic Interplay in Tumor Ecosystems: Communication between Hepatoma Cells and Fibroblasts. International journal of molecular sciences 24 (18) (2023)
Lórand Váncza, Péter Tátrai, Andrea Reszegi, Kornélia Baghy, Ilona Kovalszky
SPOCK1 with unexpected function. The start of a new career. American journal of physiology. Cell physiology 322 (4) (2022)
Andrea Reszegi, Péter Tátrai, Eszter Regős, Ilona Kovalszky, Kornélia Baghy
Syndecan-1 in liver pathophysiology. American journal of physiology. Cell physiology 323 (2) (2022)
Andrea Reszegi, Katalin Karászi, Gábor Tóth, Kristóf Rada, Lórand Váncza, Lilla Turiák, Zsuzsa Schaff, András Kiss, László Szilák, Gábor Szabó, Gábor Petővári, Anna Sebestyén, Katalin Dezső, Eszter Regős, Péter Tátrai, Kornélia Baghy, Ilona Kovalszky
Overexpression of Human Syndecan-1 Protects against the Diethylnitrosamine-Induced Hepatocarcinogenesis in Mice. Cancers 13 (7) (2021)
Zsolt Mervai, Andrea Reszegi, Ildikó Miklya, József Knoll, Zsuzsa Schaff, Ilona Kovalszky, Kornélia Baghy
Inhibitory Effect of (2R)-1-(1-Benzofuran-2-yl)-N-propylpentan-2-amine on Lung Adenocarcinoma. Pathology oncology research : POR 26 (2) (2019)
Zsolt Mervai, Krisztina Egedi, Ilona Kovalszky, Kornélia Baghy
Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse. BMC cancer 18 (1) (2018)
József Dudás, József Bocsi, Alexandra Fullár, Kornélia Baghy, Tibor Füle, Saule Kudaibergenova, Ilona Kovalszky
Heparin and liver heparan sulfate can rescue hepatoma cells from topotecan action. BioMed research international 2014 (2014)